141 related articles for article (PubMed ID: 26825432)
1. Nebivolol ameliorates asymmetric dimethylarginine-induced vascular response in rat aorta via β3 adrenoceptor-mediated mechanism.
Wang Y; Dong X
Clin Exp Hypertens; 2016; 38(2):252-9. PubMed ID: 26825432
[TBL] [Abstract][Full Text] [Related]
2. The effect of nebivolol on asymmetric dimethylarginine system in spontaneously hypertension rats.
Wang Y; Zhang M; Liu Y; Liu Y; Chen M
Vascul Pharmacol; 2011; 54(1-2):36-43. PubMed ID: 21167314
[TBL] [Abstract][Full Text] [Related]
3. Mixed beta3-adrenoceptor agonist and alpha1-adrenoceptor antagonist properties of nebivolol in rat thoracic aorta.
Rozec B; Quang TT; Noireaud J; Gauthier C
Br J Pharmacol; 2006 Apr; 147(7):699-706. PubMed ID: 16474420
[TBL] [Abstract][Full Text] [Related]
4. Differential sensitivity of basal and acetylcholine-induced activity of nitric oxide to blockade by asymmetric dimethylarginine in the rat aorta.
Al-Zobaidy MJ; Craig J; Martin W
Br J Pharmacol; 2010 Jul; 160(6):1476-83. PubMed ID: 20590637
[TBL] [Abstract][Full Text] [Related]
5. Nebivolol suppresses asymmetric dimethylarginine and attenuates cyclosporine-induced nephrotoxicity and endothelial dysfunction in rats.
Hewedy WA; Mostafa DK
Pharmacol Rep; 2016 Dec; 68(6):1319-1325. PubMed ID: 27701056
[TBL] [Abstract][Full Text] [Related]
6. Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta.
Trochu JN; Leblais V; Rautureau Y; Bévérelli F; Le Marec H; Berdeaux A; Gauthier C
Br J Pharmacol; 1999 Sep; 128(1):69-76. PubMed ID: 10498836
[TBL] [Abstract][Full Text] [Related]
7. The ability of asymmetric dimethylarginine (ADMA) or monomethylarginine (L-NMMA) to block endothelium-dependent, nitric oxide-mediated relaxation in rat aorta is inversely related to the efficacy of the relaxant stimulus.
Al-Zobaidy MJ; Martin W
Eur J Pharmacol; 2014 Oct; 741():171-7. PubMed ID: 25149663
[TBL] [Abstract][Full Text] [Related]
8. Nebivolol-induced vasodilation of renal afferent arterioles involves β3-adrenergic receptor and nitric oxide synthase activation.
Feng MG; Prieto MC; Navar LG
Am J Physiol Renal Physiol; 2012 Sep; 303(5):F775-82. PubMed ID: 22674024
[TBL] [Abstract][Full Text] [Related]
9. Stimulus-specific blockade of nitric oxide-mediated dilatation by asymmetric dimethylarginine (ADMA) and monomethylarginine (L-NMMA) in rat aorta and carotid artery.
Al-Zobaidy MJ; Craig J; Brown K; Pettifor G; Martin W
Eur J Pharmacol; 2011 Dec; 673(1-3):78-84. PubMed ID: 22056836
[TBL] [Abstract][Full Text] [Related]
10. Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol.
Dessy C; Saliez J; Ghisdal P; Daneau G; Lobysheva II; Frérart F; Belge C; Jnaoui K; Noirhomme P; Feron O; Balligand JL
Circulation; 2005 Aug; 112(8):1198-205. PubMed ID: 16116070
[TBL] [Abstract][Full Text] [Related]
11. The Beta-1-Receptor Blocker Nebivolol Elicits Dilation of Cerebral Arteries by Reducing Smooth Muscle [Ca2+]i.
Cseplo P; Vamos Z; Ivic I; Torok O; Toth A; Koller A
PLoS One; 2016; 11(10):e0164010. PubMed ID: 27716772
[TBL] [Abstract][Full Text] [Related]
12. Impairment of the low-affinity state beta1-adrenoceptor-induced relaxation in spontaneously hypertensive rats.
Mallem MY; Toumaniantz G; Serpillon S; Gautier F; Gogny M; Desfontis JC; Gauthier C
Br J Pharmacol; 2004 Nov; 143(5):599-605. PubMed ID: 15466443
[TBL] [Abstract][Full Text] [Related]
13. Effects of vasodilatory beta-adrenoceptor antagonists on endothelium-derived nitric oxide release in rat kidney.
Kakoki M; Hirata Y; Hayakawa H; Nishimatsu H; Suzuki Y; Nagata D; Suzuki E; Kikuchi K; Nagano T; Omata M
Hypertension; 1999 Jan; 33(1 Pt 2):467-71. PubMed ID: 9931149
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide-dependent beta2-adrenergic dilatation of rat aorta is mediated through activation of both protein kinase A and Akt.
Ferro A; Coash M; Yamamoto T; Rob J; Ji Y; Queen L
Br J Pharmacol; 2004 Oct; 143(3):397-403. PubMed ID: 15351777
[TBL] [Abstract][Full Text] [Related]
15. Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.
Pasini AF; Garbin U; Stranieri C; Boccioletti V; Mozzini C; Manfro S; Pasini A; Cominacini M; Cominacini L
Am J Hypertens; 2008 Nov; 21(11):1251-7. PubMed ID: 18772860
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the beta3 adrenoceptor in nebivolol-induced vasorelaxation in the rat aorta.
de Groot AA; Mathy MJ; van Zwieten PA; Peters SL
J Cardiovasc Pharmacol; 2003 Aug; 42(2):232-6. PubMed ID: 12883327
[TBL] [Abstract][Full Text] [Related]
17. Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta(2)-adrenergic receptor-mediated nitric oxide production.
Broeders MA; Doevendans PA; Bekkers BC; Bronsaer R; van Gorsel E; Heemskerk JW; Egbrink MG; van Breda E; Reneman RS; van Der Zee R
Circulation; 2000 Aug; 102(6):677-84. PubMed ID: 10931809
[TBL] [Abstract][Full Text] [Related]
18. Role of nitric oxide in beta3-adrenoceptor activation on basal tone of internal anal sphincter.
Banwait KS; Rattan S
Am J Physiol Gastrointest Liver Physiol; 2003 Sep; 285(3):G547-55. PubMed ID: 12736154
[TBL] [Abstract][Full Text] [Related]
19. Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity.
Garbin U; Pasini AF; Stranieri C; Manfro S; Boccioletti V; Cominacini L
Pharmacol Res; 2007 Dec; 56(6):515-21. PubMed ID: 17977009
[TBL] [Abstract][Full Text] [Related]
20. Asymmetric dimethylarginine endogenous inhibition of nitric oxide synthase causes differential vasculature effects.
Cable DG; Celotto AC; Evora PR; Schaff HV
Med Sci Monit; 2009 Sep; 15(9):BR248-53. PubMed ID: 19721392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
